Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis

Chitul, A.; Voiosu, A.M.; Marinescu, Mădălina; Caraiola, Simona; Nicolau, Adriana; Badea, Georgeta Camelia; Pârvu, Magda Ileana; Ionescu, R. A.; Mateescu, B. R.; Voiosu, M. R.; Băicuş, C. R.; Rimbaş, M.

doi:10.1515/rjim-2017-0001

References

1. CIUREA A., SCHERER A., EXER P., BERNHARD J., DUDLER J., BEYELER B., et al. Tumor necrosis factor alpha inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum. 2013; 65(12):3096-106.10.1002/art.38140
Search in Google Scholar Back to article
2. LEIRISALO-REPO M., TURUNEN U., STENMAN S., HELENIUS P., SEPPALA K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 1994; 37(1):23-31.10.1002/art.1780370105
Search in Google Scholar Back to article
3. DE KEYSER F., MIELANTS H. The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface. J Rheumatol. 2003; 30(11):2306-7.
Search in Google Scholar Back to article
4. DE KEYSER F., ELEWAUT D., DE VOS M., DE VLAM K., CUVELIER C., MIELANTS H., et al. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am. 1998; 24(4):785-813, ix-x.10.1016/S0889-857X(05)70042-9
Search in Google Scholar Back to article
5. BRADLEY J.R. TNF-mediated inflammatory disease. The Journal of Pathology. 2008; 214(2):149-60.10.1002/path.2287
Search in Google Scholar Back to article
6. BRAUN J., SIEPER J. Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases. Expert Opin Biol Ther. 2003; 3(1):141-68.10.1517/14712598.3.1.141
Search in Google Scholar Back to article
7. VAN DULLEMEN H.M., VAN DEVENTER S.J., HOMMES D.W., BIJL H.A., JANSEN J., TYTGAT G.N., et al. Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 1995; 109(1):129-35.10.1016/0016-5085(95)90277-5
Search in Google Scholar Back to article
8. D’HAENS G., VAN DEVENTER S., VAN HOGEZAND R., CHALMERS D., KOTHE C., BAERT F., et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: A European multicenter trial. Gastroenterology. 1999; 116(5):1029-34.10.1016/S0016-5085(99)70005-3
Search in Google Scholar Back to article
9. FORD A.C., SANDBORN W.J., KHAN K.J., HANAUER S.B., TALLEY N.J., MOAYYEDI P. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2011; 106(4):644-59, quiz 60.
Search in Google Scholar Back to article
10. JARNEROT G., HERTERVIG E., FRIIS-LIBY I., BLOMQUIST L., KARLEN P., GRANNO C., et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005; 128(7):1805-11.10.1053/j.gastro.2005.03.00315940615
Search in Google Scholar Back to article
11. SONG I.H., PODDUBNYY D.A., RUDWALEIT M., SIEPER J. Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheum. 2008; 58(4):929-38.10.1002/art.2327518383378
Search in Google Scholar Back to article
12. WATANABE T., TANIGAWA T., SHIBA M., NADATANI Y., NAGAMI Y., SUGIMORI S., et al. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients. Gut. 2014; 63(3):409-14.10.1136/gutjnl-2013-30471323697473
Search in Google Scholar Back to article
13. MAIDEN L., THJODLEIFSSON B., THEODORS A., GONZALEZ J., BJARNASON I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005; 128(5):1172-8.10.1053/j.gastro.2005.03.02015887101
Search in Google Scholar Back to article
14. WATANABE T., TANIGAWA T., NADATANI Y., OTANI K., MACHIDA H., OKAZAKI H., et al. Mitochondrial disorders in NSAIDs-induced small bowel injury. J Clin Biochem Nutr. 2011; 48(2):117-21.10.3164/jcbn.10-73304568321373263
Search in Google Scholar Back to article
15. BABB R.R. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs. West J Med. 1992; 157(4):444-7.
Search in Google Scholar Back to article
16. SIGTHORSSON G., TIBBLE J., HAYLLAR J., MENZIES I., MACPHERSON A., MOOTS R., et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut. 1998; 43(4):506-11.10.1136/gut.43.4.50617272929824578
Search in Google Scholar Back to article
17. APPLEYARD C.B., MCCAFFERTY D.M., TIGLEY A.W., SWAIN M.G., WALLACE J.L. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol. 1996; 270(1 Pt 1):G42-8.10.1152/ajpgi.1996.270.1.G428772499
Search in Google Scholar Back to article
18. CICCIA F., RIZZO A., TRIOLO G. Subclinical gut inflammation in ankylosing spondylitis. Curr Opin Rheumatol. 2016; 28(1):89-96.10.1097/BOR.000000000000023926599385
Search in Google Scholar Back to article
19. GRALNEK I.M., DEFRANCHIS R., SEIDMAN E., LEIGHTON J.A., LEGNANI P., LEWIS B.S. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2008; 27(2):146-54.10.1111/j.1365-2036.2007.03556.x17956598
Search in Google Scholar Back to article
20. ORLANDO A., RENNA S., PERRICONE G., COTTONE M. Gastrointestinal lesions associated with spondyloarthropathies. World J Gastroenterol. 2009; 15(20):2443-8.10.3748/wjg.15.2443268690019468992
Search in Google Scholar Back to article
21. DE KEYSER F., BAETEN D., VAN DEN BOSCH F., DE VOS M., CUVELIER C., MIELANTS H., et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep. 2002; 4(6):525-32.10.1007/s11926-002-0061-612427369
Search in Google Scholar Back to article
22. MIELANTS H., DE KEYSER F., BAETEN D., VAN DEN BOSCH F. Gut inflammation in the spondyloarthropathies. Curr Rheumatol Rep. 2005; 7(3):188-94.10.1007/s11926-996-0038-y15918994
Search in Google Scholar Back to article
23. ELEWAUT D. Linking Crohn’s Disease and Ankylosing Spondylitis: It’s All about Genes! PLoS Genet. 2010; 6(12).10.1371/journal.pgen.1001223299632221152009
Search in Google Scholar Back to article
24. RUDWALEIT M., BAETEN D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006; 20(3):451-71.10.1016/j.berh.2006.03.010
Search in Google Scholar Back to article
25. SENABRE-GALLEGO JÉ M., SANTOS-RAMÍREZ C., SANTOS-SOLER G., SALAS-HEREDIA E., SÁNCHEZ-BARRIOLUENGO M., BARBER X., et al. Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis. Patient Prefer Adherence. 2013; 7:961-72.10.2147/PPA.S33109
Search in Google Scholar Back to article
26. VAN DEVENTER S.J. Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn’s disease. Gastroenterology. 2001; 121(5):1242-6.10.1053/gast.2001.29035
Search in Google Scholar Back to article
27. GOLAN D.E., TASHJIAN A.H. Principles of pharmacology : the pathophysiologic basis of drug therapy. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.
Search in Google Scholar Back to article
28. VAN DEN BRANDE J.M.H., BRAAT H., VAN DEN BRINK G.R., VERSTEEG H.H., BAUER C.A., HOEDEMAEKER I., et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease. Gastroenterology. 2003; 124(7):1774-85.10.1016/S0016-5085(03)00382-2
Search in Google Scholar Back to article
29. MARZO-ORTEGA H., MCGONAGLE D., O’CONNOR P., EMERY P. Efficacy of etanercept for treatment of Crohn’s related spondyloarthritis but not colitis. Ann Rheum Dis. 2003; 62(1):74-6.10.1136/ard.62.1.74175430612480676
Search in Google Scholar Back to article
30. KRUITHOF E., DE RYCKE L., ROTH J., MIELANTS H., VAN DEN BOSCH F., DE KEYSER F., et al. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. Arthritis Rheum. 2005; 52(12):3898-909.10.1002/art.2142616329106
Search in Google Scholar Back to article
31. VAN DER HEIJDE D., DIJKMANS B., GEUSENS P., SIEPER J., DEWOODY K., WILLIAMSON P., et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum. 2005; 52(2):582-91.10.1002/art.2085215692973
Search in Google Scholar Back to article
32. KRUITHOF E., BAETEN D., VAN DEN BOSCH F., MIELANTS H., VEYS E.M., DE KEYSER F. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy. Ann Rheum Dis. 2005; 64(4):529-36.10.1136/ard.2003.018549175546115388510
Search in Google Scholar Back to article
33. BRAUN J., BARALIAKOS X., LISTING J., DAVIS J., VAN DER HEIJDE D., HAIBEL H., et al. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum. 2007; 57(4):639-47.10.1002/art.2266917471540
Search in Google Scholar Back to article
34. PODDUBNYY D. Axial spondyloarthritis: is there a treatment of choice? Ther Adv Musculoskelet Dis. 2013; 5(1):45-54.10.1177/1759720X12468658358230523514983
Search in Google Scholar Back to article
35. MIELANTS H., VEYS E.M., DE VOS M., CUVELIER C., GOEMAERE S., DE CLERCQ L., et al. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol. 1995; 22(12):2266-72.
Search in Google Scholar Back to article
36. MIELANTS H., VEYS E.M., CUVELIER C., DE VOS M., GOEMAERE S., DE CLERCQ L., et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol. 1995; 22(12):2279-84.
Search in Google Scholar Back to article
37. MIELANTS H., VEYS E.M., CUVELIER C., DE VOS M., GOEMAERE S., DE CLERCQ L., et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 1995; 22(12):2273-8.
Search in Google Scholar Back to article

Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis

References

Paradigm

My account